Cancer
VIDEO: Patients with cancer, survivors benefit from lifestyle medicine interventions
ORLANDO — Mass General Cancer Center has found success in an oncology-focused lifestyle medicine clinic, proving that the model can be sustainable and beneficial, according to a poster presented at the Lifestyle Medicine Conference.
'Stark' finding: Cancer research in US increasingly dominated by industry sponsors
Industry-sponsored clinical trials have enrolled significantly more participants than federally sponsored trials over the past decade, according to retrospective study results.
Serious adverse event risk after egg freezing similar for women with vs. without cancer
DENVER — Women with cancer had similar serious adverse event risk as women without cancer after undergoing fertility preservation procedures, according to study results presented at the ASRM Scientific Congress & Expo.
Half of newly approved drugs exempt from pediatric testing
Less than half of drugs approved between 2015 and 2021 were required to conduct pediatric trials under the Pediatric Research Equity Act, according to findings published in JAMA.
Dip in cancer-related deaths among younger adults linked to ACA’s dependent coverage
Young adults with cancer who were eligible for the Affordable Care Act’s dependent care expansion had greatly improved survival times during the first decade of the ACA, an analysis in Cancer showed.
Cancer risk elevated for adults after Cushing’s syndrome diagnosis
Adults diagnosed with endogenous Cushing’s syndrome have a higher risk for developing cancer compared with controls without the condition, according to data published in the European Journal of Endocrinology.
Gut microbiota in older cancer survivors linked to cognitive function
ORLANDO, Fla. — An analysis of the gut microbiome among individuals who survived cancer revealed a significant association between the gut-brain axis, particularly in gut microbiota, metabolism and cognitive function, according to a poster.
Dermatology groups hope to see U.S. surgeon general extend skin cancer call to action
Leading dermatology organizations called on the U.S. surgeon general to continue its call to action to prevent skin cancer, the American Society for Dermatologic Surgery Association announced in a press release.
FDA grants fast track designation to ATR-04 for cancer therapy-induced skin rash
The FDA has granted fast track designation to topically applied ATR-04 for the treatment of moderate to severe epidermal growth factor receptor inhibitor-associated dermal toxicity, Azitra announced in a press release.
Fewer cancer drugs exempt from pediatric testing after RACE Act
Fewer cancer drugs were exempt from pediatric testing requirements after the Research to Accelerate Cures and Equity, or RACE, for Children Act went into effect in 2020, a study showed.